Skip to content

Gilead Sciences GILD Price / earnings

Price / earnings at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
17×-6.2×
Incyte logo
IncyteINCY
13.1×-538×
Merck & Co. logo
Merck & Co.MRK
33.3×+20.3×
Johnson & Johnson logo
Johnson & JohnsonJNJ
28×+9.7×
ALN
Alnylam PharmaceuticalsALNY
87.4×
Biogen logo
BiogenBIIB
18.9×+5.4×

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$155.75B+23.8%
Enterprise value$170.3B+19.7%
P/S5.2×+0.9×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Where this comes from

Calculated from Gilead Sciences’s reported figures.

Based on the most recent quarter.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gilead Sciences's price / earnings?
Gilead Sciences (GILD) reported price / earnings of 18.8× in Q1 2026.
How has Gilead Sciences's price / earnings changed year-over-year?
Gilead Sciences's price / earnings decreased by 19.8% year-over-year, from 23.4× to 18.8×.
What is the long-term trend for Gilead Sciences's price / earnings?
Over 4 years (2021 to 2025), Gilead Sciences's price / earnings has grown at a -29.0% compound annual growth rate (CAGR), from 312.6× to 79.4×.
What does price / earnings mean?
How many dollars investors pay for each dollar of the company's annual profit.
How do you interpret price / earnings?
Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
How does price / earnings compare across companies?
Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.